US20080220025A1
(en)
*
|
1995-03-17 |
2008-09-11 |
James Thompson |
Treating Tumors Using Implants Comprising Combinations of Allogeneic Cells
|
US7361332B2
(en)
*
|
1995-03-17 |
2008-04-22 |
The Regents Of The University Of California |
Treating tumors using implants comprising combinations of allogeneic cells
|
WO1998048000A2
(en)
*
|
1997-04-23 |
1998-10-29 |
The Regents Of The University Of California |
A cell strain with activated anti-cancer cytotoxic activity
|
AU9794698A
(en)
|
1997-10-10 |
1999-05-03 |
Regents Of The University Of California, The |
Enhanced immunogenic cell populations prepared using h2 receptor antagonists
|
CA2346735C
(en)
|
1997-10-10 |
2005-01-25 |
Meyer Pharmaceuticals, Llc |
Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
|
CA2346769C
(en)
|
1997-10-10 |
2004-09-14 |
The Regents Of The University Of California |
Implants comprising combinations of allogeneic cells for use in cancer treatment
|
JP4389039B2
(ja)
*
|
1998-04-09 |
2009-12-24 |
株式会社リンフォテック |
アロジェニックな活性化cd4陽性細胞を主成分とする医薬組成物、およびその製造方法、ならびに該医薬組成物調製用キット
|
US7666609B1
(en)
|
1998-12-01 |
2010-02-23 |
Shanghai Cp Guojian Pharmaceutical Co. Ltd. |
Method and composition for diagnosis of melanocytic lesions
|
CA2362578A1
(en)
*
|
1999-02-09 |
2000-08-17 |
Kam Leong |
Tumor vaccines
|
DE60144515D1
(de)
|
2000-04-01 |
2011-06-09 |
Onyvax Ltd |
Prostata zellinien und deren verwendung
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US6984522B2
(en)
*
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
DE10043437A1
(de)
*
|
2000-09-04 |
2002-03-28 |
Horst Lindhofer |
Verwendung von trifunktionellen bispezifischen und trispezifischen Antikörpern zur Behandlung von malignem Aszites
|
US7723111B2
(en)
*
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
ATE500808T1
(de)
*
|
2001-05-11 |
2011-03-15 |
Wellstat Biologics Corp |
Onkolytische virustherapie
|
US7658926B2
(en)
*
|
2001-09-14 |
2010-02-09 |
Opexa Pharmaceuticals, Inc. |
Autologous T-cell vaccines materials and methods
|
EP1293205A1
(en)
*
|
2001-09-18 |
2003-03-19 |
G2M Cancer Drugs AG |
Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
|
ATE386129T1
(de)
*
|
2001-11-27 |
2008-03-15 |
Nexyte Ab |
Produktion eukaryontischer proteine und nukleinsäuremoleküle in c. elegans
|
KR20020060643A
(ko)
*
|
2002-06-04 |
2002-07-18 |
김진경 |
타인의 면역시스템을 이용하는 암의 치료 방법
|
EP1546719B1
(en)
*
|
2002-08-08 |
2015-04-01 |
Baylor College Of Medicine |
Isolation and identification of t cells
|
US7571817B2
(en)
*
|
2002-11-06 |
2009-08-11 |
Varco I/P, Inc. |
Automatic separator or shaker with electromagnetic vibrator apparatus
|
WO2004075855A2
(en)
|
2003-02-26 |
2004-09-10 |
Biomed Solutions, Llc |
Process for in vivo treatment of specific biological targets in bodily fluid
|
KR20040094635A
(ko)
*
|
2003-05-02 |
2004-11-10 |
주식회사 엠디바이오알파 |
항종양 활성의 유도를 위한 종양 백신의 제조방법 및그것을 함유하고 있는 약제 조성물
|
CA2529058A1
(en)
|
2003-06-11 |
2005-01-13 |
The University Of Chicago |
Increased t-cell tumor infiltration by mutant light
|
US7811983B2
(en)
*
|
2003-06-11 |
2010-10-12 |
The University Of Chicago |
Increased T-cell tumor infiltration and eradication of metastases by mutant light
|
US20050019336A1
(en)
|
2003-07-23 |
2005-01-27 |
Dalgleish Angus George |
Human prostate cell lines in cancer treatment
|
US7696322B2
(en)
*
|
2003-07-28 |
2010-04-13 |
Catalent Pharma Solutions, Inc. |
Fusion antibodies
|
NZ597965A
(en)
*
|
2003-10-08 |
2013-09-27 |
Vet Stem Inc |
Methods of preparing and using stem cell compositions and kits comprising the same
|
US8029454B2
(en)
|
2003-11-05 |
2011-10-04 |
Baxter International Inc. |
High convection home hemodialysis/hemofiltration and sorbent system
|
US20050112684A1
(en)
*
|
2003-11-21 |
2005-05-26 |
Eric Holzle |
Class I and Class II MHC Profiling for Social and Sexual Matching of Human Partners
|
ATE552851T1
(de)
|
2004-02-03 |
2012-04-15 |
Univ Michigan |
Zusammensetzungen zur behandlung von brust- und bauchspeicheldrüsenkrebs
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
US8257715B1
(en)
|
2004-08-26 |
2012-09-04 |
University Of Notre Dame |
Tissue vaccines and uses thereof
|
US9155789B2
(en)
*
|
2005-04-25 |
2015-10-13 |
New York University |
Use of allogenic or syngenic major histocompatibility complex (MHC) molecules as universal adjuvants for vaccines against neoplastic disease, infection and autoimmune disease
|
US20090162405A1
(en)
*
|
2006-12-14 |
2009-06-25 |
Yong Qian |
Proteinase-engineered cancer vaccine induces immune responses to prevent cancer and to systemically kill cancer cells
|
US9308252B2
(en)
*
|
2005-10-27 |
2016-04-12 |
Cook Biotech, Inc. |
Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
|
US8778360B2
(en)
*
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
US8778362B2
(en)
|
2005-10-27 |
2014-07-15 |
University Of Notre Dame |
Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
|
US8802113B2
(en)
*
|
2005-10-27 |
2014-08-12 |
University Of Notre Dame |
Extracellular matrix cancer vaccine adjuvant
|
JP5129149B2
(ja)
*
|
2005-10-31 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を処置および診断するための組成物および方法
|
JP2009513708A
(ja)
|
2005-10-31 |
2009-04-02 |
オンコメッド ファーマシューティカルズ インコーポレイテッド |
癌の診断および処置のための組成物および方法
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
US20080019961A1
(en)
*
|
2006-02-21 |
2008-01-24 |
Regents Of The University Of Michigan |
Hedgehog signaling pathway antagonist cancer treatment
|
US20070243192A1
(en)
*
|
2006-02-21 |
2007-10-18 |
Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
US20100003228A1
(en)
*
|
2006-05-05 |
2010-01-07 |
Willimas Jim C |
T-cell vaccine
|
RU2009107494A
(ru)
|
2006-08-04 |
2010-09-10 |
Астразенека Аб (Se) |
АНТИТЕЛА К ErbB2
|
US7972594B2
(en)
*
|
2006-11-13 |
2011-07-05 |
Immunovative Therapies Ltd. |
Ablative immunotherapy
|
US8691568B2
(en)
*
|
2006-11-22 |
2014-04-08 |
Hua Liu |
Method for preparing cell populations with anti-tumor immune response activity
|
US20080147007A1
(en)
*
|
2006-12-19 |
2008-06-19 |
Toby Freyman |
Delivery device with pressure control
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
US8455188B2
(en)
*
|
2007-01-26 |
2013-06-04 |
University Of Louisville Research Foundation, Inc. |
Modification of exosomal components for use as a vaccine
|
US20090093429A1
(en)
*
|
2007-02-08 |
2009-04-09 |
Yang-Xin Fu |
Combination therapy for treating cancer
|
ES2433967T3
(es)
|
2007-05-14 |
2013-12-13 |
The University Of Chicago |
Productos de fusión anticuerpo-LIGHT como productos terapéuticos de cáncer
|
AU2008299318A1
(en)
*
|
2007-09-12 |
2009-03-19 |
The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center |
Methods of treating tumors in immune-privileged sites
|
US8114276B2
(en)
|
2007-10-24 |
2012-02-14 |
Baxter International Inc. |
Personal hemodialysis system
|
US9283266B2
(en)
*
|
2008-02-28 |
2016-03-15 |
University Of Notre Dame |
Metastasis inhibition preparations and methods
|
AU2009296246B2
(en)
|
2008-09-26 |
2015-07-30 |
Oncomed Pharmaceuticals, Inc. |
Frizzled-binding agents and uses thereof
|
AU2009308707A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Biogen Idec Ma Inc. |
LIGHT targeting molecules and uses thereof
|
NZ602369A
(en)
|
2008-11-11 |
2015-02-27 |
Univ Michigan |
Anti-cxcr1 compositions and methods
|
CU23740A1
(es)
*
|
2009-09-29 |
2011-12-28 |
Ct Ingenieria Genetica Biotech |
Método de obtención de una formulación de antígenos del virus de la hepatitis b
|
CA2796379A1
(en)
*
|
2009-10-27 |
2011-05-05 |
Immunicum Ab |
Method for proliferation of antigen-specific t cells
|
AU2010341703B2
(en)
*
|
2009-12-08 |
2016-01-21 |
The Board Of Trustees Of The University Of Illinois |
Stem cell immune modulation methods of use and apparatus
|
US8846059B2
(en)
|
2009-12-08 |
2014-09-30 |
University Of Notre Dame |
Extracellular matrix adjuvant and methods for prevention and/or inhibition of ovarian tumors and ovarian cancer
|
US20110150934A1
(en)
*
|
2009-12-18 |
2011-06-23 |
University Of Notre Dame |
Ovarian Tumor Tissue Cell Preparations/Vaccines for the Treatment/Inhibition of Ovarian Tumors and Ovarian Cancer
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
EP2548025A4
(en)
|
2010-03-17 |
2013-09-25 |
Univ Michigan |
USE OF PHOTOEPITOPES FOR PROFILING AN IMMUNE REACTION
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
WO2011129348A1
(ja)
*
|
2010-04-13 |
2011-10-20 |
株式会社Reiメディカル |
癌組織由来細胞塊または癌細胞凝集塊から得られる癌治療用組成物およびそれを用いた免疫療法剤の製造方法ならびに免疫療法効果評価方法
|
CA2838041C
(en)
*
|
2011-05-03 |
2018-09-25 |
Immunovative Therapies, Ltd. |
Methods for handling biological drugs containing living cells
|
HRP20211595T1
(hr)
*
|
2011-05-24 |
2022-01-21 |
BioNTech SE |
Individualizirana cjepiva protiv raka
|
CA2858876A1
(en)
|
2011-12-15 |
2013-06-20 |
The University Of Chicago |
Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors
|
CA2887711A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
CN105073195A
(zh)
|
2013-02-04 |
2015-11-18 |
昂科梅德制药有限公司 |
使用Wnt途径抑制剂进行治疗的方法及对该治疗的监测
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
EP3049155A1
(en)
*
|
2013-09-27 |
2016-08-03 |
Vaccinogen International Partners, LP |
Autologous tumor vaccines and methods
|
PE20171135A1
(es)
|
2014-11-05 |
2017-08-09 |
Memorial Sloan Kettering Cancer Center |
Metodos para seleccionar una linea de celulas t y donador de la misma para terapia celular adoptiva
|
WO2016145292A1
(en)
*
|
2015-03-12 |
2016-09-15 |
University Of Iowa Research Foundation |
Vaccine, therapeutic composition and methods for treating or inhibiting cancer
|
JP2018518527A
(ja)
*
|
2015-06-26 |
2018-07-12 |
メモリアル スローン ケタリング キャンサー センター |
T細胞療法によるcmv網膜炎の治療方法
|
WO2017023803A1
(en)
|
2015-07-31 |
2017-02-09 |
Regents Of The University Of Minnesota |
Modified cells and methods of therapy
|
US11219645B2
(en)
|
2015-11-18 |
2022-01-11 |
Duke University |
Tumor infiltrating lymphocytes for treatment of cancer
|
GB2573406B
(en)
|
2016-10-18 |
2021-11-10 |
Univ Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
WO2018138682A1
(en)
|
2017-01-26 |
2018-08-02 |
Immune Therapeutics |
Methods and compositions useful for treating cancer
|
EP3645021A4
(en)
|
2017-06-30 |
2021-04-21 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
KR102256337B1
(ko)
*
|
2017-10-17 |
2021-05-26 |
(주)노터스생명과학 |
조직이식을 위한 세포배양액을 포함하는 면역억제제
|
US11446329B2
(en)
|
2017-11-01 |
2022-09-20 |
Restem Llc |
Natural killer cell adoptive transfer therapy for the elimination of senescent PBMCs, reduction of inflammatory cytokines and treatment of IBS
|
IL259392A
(en)
|
2018-05-15 |
2018-08-01 |
Yeda Res & Dev |
Vaccination with cancer neo-antigens
|
FR3082730B1
(fr)
*
|
2018-06-21 |
2022-04-22 |
Med Inn Pharma |
Methode de resolution de l'inflammation pro-tumorale a l'aide d'une preparation pharmaceutique
|
WO2023196232A1
(en)
*
|
2022-04-04 |
2023-10-12 |
University Of Florida Research Foundation, Inc. |
Method of characterizing tumors
|
CN114984199A
(zh)
*
|
2022-04-19 |
2022-09-02 |
苏州尔生生物医药有限公司 |
一种基于癌症特异性t细胞的细胞系统、淋巴细胞药物及其应用
|